by Fadi Agour | Apr 28, 2023 | Mass Torts
In December of last year, the federal court judge overseeing the MDL relating to Zantac claims effectively dismissed all cases against GSK. This was most certainly the worst news possible, but can Zantac claims possibly make a comeback? Potentially yes, with a few...
by Fadi Agour | Apr 19, 2023 | Mass Torts
By Ken Hardison Artificial Intelligence (AI) has become one of the hottest topics taking the business world by storm. This cutting edged technology has tremendous application for today’s law firms. Unlike the Metaverse, which garnered significant initial interest but...
by Fadi Agour | Apr 19, 2023 | Mass Torts
By W. Cameron Stephenson, Esq. Levin Papantonio Rafferty JOHNSON & JOHNSON’S ATTEMPT TO AVOID TALC LIABILITY THROUGH ABUSE OF U.S. BANKRUPTCY CODE DID NOT WORK Global giant Johnson & Johnson concentrates its business in pharmaceutical, medical...
Recent Comments